Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).
Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, Tan CE, Wittchen HU, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP; INSPIRE ME IAA Investigators. Nazare JA, et al. Among authors: aschner p. Am J Cardiol. 2015 Feb 1;115(3):307-15. doi: 10.1016/j.amjcard.2014.10.039. Epub 2014 Nov 13. Am J Cardiol. 2015. PMID: 25499404
Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America.
Aschner P, Ruiz A, Balkau B, Massien C, Haffner SM; Latin America and the Caribbean International Day for Evaluation of Abdominal Adiposity (IDEA) National Coordinators and Investigators. Aschner P, et al. J Clin Hypertens (Greenwich). 2009 Dec;11(12):769-74. doi: 10.1111/j.1559-4572.2008.00051.x. J Clin Hypertens (Greenwich). 2009. PMID: 20021540 Free PMC article.
Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA.
Smith J, Nazare JA, Borel AL, Aschner P, Barter PJ, Van Gaal L, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP. Smith J, et al. Among authors: aschner p. Diabetes Obes Metab. 2013 Jul;15(7):629-41. doi: 10.1111/dom.12075. Epub 2013 Feb 24. Diabetes Obes Metab. 2013. PMID: 23356633
Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.
Borel AL, Nazare JA, Smith J, Aschner P, Barter P, Van Gaal L, Eng Tan C, Wittchen HU, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP. Borel AL, et al. Among authors: aschner p. Int J Obes (Lond). 2015 Mar;39(3):495-501. doi: 10.1038/ijo.2014.163. Epub 2014 Sep 2. Int J Obes (Lond). 2015. PMID: 25179244
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
Pagidipati NJ, Zheng Y, Green JB, McGuire DK, Mentz RJ, Shah S, Aschner P, Delibasi T, Rodbard HW, Westerhout CM, Holman RR, Peterson ED; TECOS Study Group. Pagidipati NJ, et al. Among authors: aschner p. Am Heart J. 2020 Jan;219:47-57. doi: 10.1016/j.ahj.2019.09.016. Epub 2019 Oct 20. Am Heart J. 2020. PMID: 31707324 Clinical Trial.
Diabetes trends in Latin America.
Aschner P. Aschner P. Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S27-31. doi: 10.1002/dmrr.280. Diabetes Metab Res Rev. 2002. PMID: 12324982 Review.
91 results